Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A1P13 is a processed non-coding pseudogene of the human EEF1A1 gene, located at a distinct genomic locus but not encoding a functional protein[1][2][4][6]. While the protein-coding parent gene EEF1A1 is essential for protein synthesis by delivering aminoacyl-tRNAs to the ribosome during the elongation phase of mRNA translation, EEF1A1P13 itself is not known to produce protein or have a direct functional role[1][5][3][7]. Among EEF1A1 pseudogenes, EEF1A1P13 has no reported independent biological or pathological function, though it has been observed to be downregulated in patients with Chikungunya virus infection[1]. There are no known drug interactions, mechanisms of action, or established disease biomarker roles for this pseudogene. It is not regarded as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 13 (EEF1A1P13).